Form D · Pharmaceuticals
PharmAbbie, Inc.
Groton, CT · CIK 0001877360
Offering snapshot reported Aug 12, 2021 · SEC filing
- Reported sold
- Yet to sell Offering amount: $15M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 12, 2021 | Initial | Yet to sell | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-409788
Source: Form D, filed Aug 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Serge R. Martinod | Director, Executive |
| Disma Mazzola | Director |
| George Murphy | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
37 Skyline Drive
Groton, CT, 06340
Groton, CT, 06340